Admission Date:  [**2112-7-10**]              Discharge Date:   [**2112-7-15**]  Date of Birth:  [**2034-5-16**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins  Attending:[**First Name3 (LF) 2181**] Chief Complaint: Shortness of breath  Major Surgical or Invasive Procedure: Patient had a repeat bronchoscopy on [**2112-7-11**], performed by Dr. [**First Name8 (NamePattern2) **] [**Name (STitle) **], to observe the patency of the stent previously placed in his left mainstem bronchus for invasive esophageal cancer.
Report stated that the stent was approximately 50% obstructed by tumor/granulation tissue, and showed proximal migration of the stent into the trachea, jailing the right mainstem bronchus.
Removal of the stent was not recommended due to tumor ingrowth, and balloon dilation of the stent would be considered if the patient continued to have problems with airway obstruction.
History of Present Illness: 78M w/ esophageal CA (s/p resection and stent placement), prostate CA, and GERD presenting from an OSH after admission for respiratory failure.
He tolerated the procedure well w/out need for intubation and was called out to medicine for further management.
Past Medical History: - Esophageal adenocarcinoma s/p Ivor-[**Doctor Last Name **] esophagectomy [**4-12**] with recurrence [**2110**], currently undergoing chemotherapy - s/p left mainstem bronchus stenting [**2-17**] [**2-12**] tumor invasion, complicated by cardiogenic shock, bronch in [**6-16**] revealed some proximal stent migration and nonobstructive (50-60% of lumen) tumor growth at the distal end of the stent - Prostate CA s/p XRT (dx ~10 years ago), currently on Casodex and Zoladex - Throat cancer in [**2096**] s/p radiation and surgery - GERD   Social History: The patient [**Doctor Last Name **] with family ( wife and grand-daughter).
Physical Exam: PE: 97.3, 180/90, 83, 20, 98% 4L Gen: Elderly [**Male First Name (un) 4746**] lying in bed in NAD HEENT: MMM, O/P clear, pupils equal and reactive, no cervical LAD CV: RRR, 2/6 SEM at the LUBS Lungs: Coarse inspiratory and expiratory breath sounds w/ a prolonged expiratory phase (L>R) Abd: S/NT/ND, +BS, -HSM Ext: No C/C/E, cool but quick capillary refill Neuro: Appropriate in conversation and moving all his extremities spontaneously Skin: No rashes   Pertinent Results: [**2112-7-11**] 04:57AM BLOOD WBC-7.4 RBC-3.52* Hgb-11.6* Hct-33.8* MCV-96 MCH-32.9* MCHC-34.3 RDW-18.7* Plt Ct-175 [**2112-7-15**] 06:10AM BLOOD WBC-7.2 RBC-3.52* Hgb-11.8* Hct-33.4* MCV-95 MCH-33.5* MCHC-35.4* RDW-17.9* Plt Ct-214 [**2112-7-14**] 03:40AM BLOOD PT-12.5 PTT-26.0 INR(PT)-1.1 [**2112-7-11**] 04:57AM BLOOD Glucose-145* UreaN-20 Creat-0.9 Na-141 K-3.2* Cl-103 HCO3-30 AnGap-11 [**2112-7-15**] 06:10AM BLOOD Glucose-100 UreaN-9 Creat-0.8 Na-139 K-3.8 Cl-99 HCO3-34* AnGap-10 [**2112-7-14**] 03:07PM BLOOD Calcium-8.6 Phos-2.3* Mg-2.0 [**2112-7-13**] 08:04PM BLOOD Type-ART pO2-346* pCO2-51* pH-7.37 calTCO2-31* Base XS-3 [**2112-7-13**] 06:28PM BLOOD Type-ART pO2-160* pCO2-113* pH-7.05* calTCO2-33* Base XS--2RESPIRATORY CULTURE (Final [**2112-3-8**]):       OROPHARYNGEAL FLORA ABSENT.
Oxacillin RESISTANT Staphylococci MUST be reported as also          RESISTANT to other penicillins, cephalosporins, carbacephems,          carbapenems, and beta-lactamase inhibitor combinations.
Rifampin should not be used alone for therapy.
Probable arterial central catheter placement.
Progression of mediastinal metastatic disease, including lymphadenopathy and mediastinal and left hilar mass.
No significant change compared to the previous tracing of [**2112-7-10**]   Brief Hospital Course: At [**Hospital1 18**], he underwent repeat broncoscopy showing a proximal migration of his stent w/ near-complete obstruction of the R mainstem bronchus.
He tolerated the procedure well w/out need for intubation and was called out to medicine for further management.
He was continued on IV Vancomycin for his MRSA pneumonia.
He notes that his breathing is much better than it was at home and he denied any CP, abdominal pain, N/V, diarrhea, weakness, paresthesias, HA, or dizziness.
He was transferred to MICU, given Metoprolol 25mg TID, and his HR dropped to 80s.
Radiation Oncology consulted with the patient, and after reviewing his old records, and discussing the patient's goals of treatment, it was decided not to proceed with further radiation.
His metoprolol was increased to 37.5mg PO tid, and he did not have any further runs of VT on [**7-15**].
The patient's breathing and cough continued to be a problem, and were both relieved with nebulizers, saline mask, mucinex, guafenesin with codeine.
He was instructed to follow-up with interventional pulmonology, and to continue a course of linezolid.
Medications on Admission: Lansoprazole 30 mg daily Albuterol/Ipratropium q6hrs prn Casodex 50 mg daily Zoladex every three months Cough syrup with codeine  Discharge Medications: 1.
Linezolid 600 mg Tablet [**Month/Day (4) **]: One (1) Tablet PO twice a day for 6 days.
Linezolid 600 mg Tablet [**Month/Day (4) **]: One (1) Tablet PO twice a day for 1 days.
Ipratropium Bromide 0.02 % Solution [**Month/Day (4) **]: One (1)  Inhalation Q6H (every 6 hours).
Metoprolol Tartrate 25 mg Tablet [**Month/Day (4) **]: 1.5 Tablets PO TID (3 times a day).
Lansoprazole 30 mg Capsule, Delayed Release(E.C.)
Insulin Regular Human 100 unit/mL Solution [**Month/Day (4) **]: per home sliding scale  Injection ASDIR (AS DIRECTED).
Casodex 50 mg Tablet [**Month/Day (4) **]: One (1) Tablet PO once a day.
Zoladex 10.8 mg Implant [**Month/Day (4) **]: One (1)  Subcutaneous every three months.
Discharge Disposition: Home With Service  Facility: [**Hospital3 **] VNA  Discharge Diagnosis: MRSA Pneumonia multifocal atrial tachycardia Esophageal cancer   Discharge Condition: stable, no O2 requirement, afebrile   Discharge Instructions: Please take your medication as prescribed and go to your follow-up appointments.
